Clinical Features of Pediatric Acute Myeloid Leukemia with TP53 and CDKN2A/2B copy Number Alterations
Yusuke Hara(Kitasato University), Yasuhide Hayashi(Gunma Children's Medical Center), Keizo Horibe(National Hospital Organization), Manabu Sotomatsu(Gunma Children's Medical Center), Daisuke Tomizawa(National Center For Child Health and Development), Yuichi Shiraishi(The University of Tokyo), Kenichi Yoshida(Kyoto University), Takashi Taga(Erasmus MC), Norio Shiba(Gunma University), Akira Shimada(Tohoku University), H. Matsuo(Kyoto University), Kentaro Ohki(National Center For Child Health and Development), Seishi Ogawa(Keio University), Genki Yamato(Gunma University), Souichi Adachi(Kyoto University), Etsuro Ito(Okayama University), Nobutaka Kiyokawa(National Center For Child Health and Development), Tsutomu Toki(Hirosaki University), Hirokazu Arakawa(Institute of Molecular and Cell Biology), Tomohiko Taki(Kyorin University), Satoru Miyano(Cardiovascular Institute Hospital), Yusuke Shiozawa(Atrium Health Wake Forest Baptist), Taeko Kaburagi(Gunma University)
Cited by 1
Related Papers
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data
|Blood|2022|2.8k
Childhood Acute Lymphoblastic Leukemia: Progress Through Collaboration
|Journal of Clinical Oncology|2015|1k
Implications of TP53 allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromes
|Nature Medicine|2020|633
Diagnosis and management of acute myeloid leukemia in children and adolescents: recommendations from an international expert panel
|Blood|2012|575
Plasma levels of adrenomedullin, a newly identified hypotensive peptide, in patients with hypertension and renal failure.
|Journal of Clinical Investigation|1994|478